-
Mar 8, 2021, 01:00 AM
by
User Not Found
Bio-IT World | New products and company updates from around Bio-IT including Seven Bridges’ partnership with Pfizer, Illumina’s Russian approval, new methylation detection platform from Twist, and more.
Full story
-
Mar 5, 2021, 01:00 AM
by
User Not Found
Bio-IT World I Variant that emerged in the UK could be more transmissible, SARS-CoV-2 may be particularly attracted to blood group A respiratory cells, a balanced T cell response is key to clearing virus without symptoms, and out-of-place large bone marrow cells responsible for brain fog. Plus: Heart muscle cells a target and could lead to cell death, interfere with heart muscle contraction and MIS-C patients have highly activated immune systems that are similar to adult COVID-19 patients.
Full story
-
Mar 4, 2021, 01:00 AM
by
User Not Found
Bio-IT World | A host of sponsors and vendor companies attended the virtual AGBT General Meeting this week. Through sponsored talks and even more poster sessions, vendor companies shared their latest work and technology developments and made product announcements.
Full story
-
Mar 3, 2021, 01:00 AM
by
User Not Found
Bio-IT World | Neville Sanjana from the New York Genome Center and NYU turned his attention to COVID-19 early in the pandemic. For several years, his lab has focused on using CRISPR to identify which regions of the genome drive disease. Last year, he applied that expertise to using genome-wide CRISPR screens to look for COVID-19 risk factors.
Full story
-
Mar 2, 2021, 14:37 PM
by
User Not Found
Bio-IT World | Our current version of the human reference genome does not adequately represent genetic diversity in the human population, Karen Miga told the virtual audience at this week’s AGBT General Meeting. The Human Pangenome Reference Consortium and the Telomere-to-Telomere Consortium are working to change that.
Full story
-
Mar 1, 2021, 16:51 PM
by
User Not Found
Bio-IT World | Josh Denny, CEO of NIH’s All of Us program, gave an update on the population sequencing program in the opening session of the virtual AGBT General Meeting this week.
Full story
-
Mar 1, 2021, 09:38 AM
by
Full story
-
Mar 1, 2021, 09:38 AM
by
A good choice of excipient can lead to the formulation of stable dosage forms. To better meet the increasing demand for excipients, Formulationbio supplies a wide range of excipients for different research purposes, including binders, lubricants, diluents, disintegrants, emulsifiers, plasticizers, surfactants, sweeteners, fillers, stabilizers and so on.
Full story
-
Mar 1, 2021, 09:38 AM
by
Full story
-
Mar 1, 2021, 09:38 AM
by
Full story
-
Mar 1, 2021, 09:38 AM
by
Full story
-
Mar 1, 2021, 09:38 AM
by
• Former 19-year McCann Health veteran, latterly President of the Americas, Amar Urhekar, joins as Global President of the >1,450 people-strong Ashfield Health network.
• Ashfield Digital and Creative (UK), Cambridge BioMarketing (US) and Pegasus (UK) merge to form Mind+Matter, a new global, data-driven creative communications agency.
• Ashfield Health’s 14 medical and scientific communications agencies come together to create Ashfield MedComms, a new 700 strong global powerhouse.
• Ashfield Health agencies unified by common brand identity and shared new purpose to ‘make it matter’
Full story
-
Mar 1, 2021, 09:38 AM
by
John Snow Labs announces first-ever Healthcare NLP Summit, being held virtually from April 6-9.
Full story
-
Mar 1, 2021, 09:38 AM
by
Full story
-
Mar 1, 2021, 09:38 AM
by
SeqOnce Biosciences, Inc., announced today the launch of its new AzureSeq One-Step Universal RT-qPCR kit for the detection of the novel coronavirus SARS-CoV-2 N501Y variant. The AzureSeq One-Step Universal SARS-CoV-2 RT-qPCR N501Y kit uses a single-tube reaction targeting the N1 nucleocapsid gene, both alleles of S gene N501Y (A23063T), and includes RNaseP as a control. The assay uses common qPCR instruments with detection channels of FAM, HEX, Cy5, and ROX.
Full story
-
Mar 1, 2021, 09:34 AM
by
Full story
-
Mar 1, 2021, 09:34 AM
by
In recent research at BIOTEC1 a three-step fragment-based screening of PfDHFR was undertaken employing Key Organics BIONET Premium library containing 1163 fragments. This library was chosen over other commercial ones as it is rule-of-three compliant and was curated from any PAINS and aggregating compounds. All fragments are also soluble at 200 mM in DMSO and display high diversity.
Full story
-
Mar 1, 2021, 09:34 AM
by
CloudLIMS’ COVID-19 LIMS solution has integrated with Folio's mobile app to enable receiving, storing, and sharing of COVID-19 test results securely and digitally.
Full story
-
Mar 1, 2021, 09:32 AM
by
ComputaBio, a US supplier of computational biology services, claims to be a capable helping hand in drug design for industrial and academic scientists worldwide to expedite their drug development projects.
Full story
-
Mar 1, 2021, 09:32 AM
by
Full story